Photo Therapeutics has received the FDA approval for its new over-the-counter light therapy device, Omnilux New-U, for the treatment of periorbital wrinkles.
Subscribe to our email newsletter
Omnilux New-U has been clinically proven to reduce periorbital wrinkles and to treat the visible signs of aging, using a combination of alternate treatments of infrared and red light twice a week for four weeks.
Sue D’Arcy, CEO of Photo Therapeutics, said: “We believe in producing light therapy devices that deliver optimized treatment parameters that have been rigorously tested and clinically proven, and our latest technological achievement is no different.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.